objective authors investigated combined experience single institution treating bile duct carcinoma modern era summary background data bile duct carcinomas notoriously difficult cure locoregional recurrence rule radical resection adjuvant efforts included various radiation modalities limited success recently radiotherapy used patients methods authors performed retrospective chart analysis NUMBER patients bile duct adenocarcinomas treated NUMBER NUMBER university california san francisco including NUMBER patients treated lawrence berkeley laboratory charged particles helium neon minimum NUMBER years survival outcome complication results analyzed results patients treated surgery s NUMBER patients received conventional adjuvant radiotherapy s x NUMBER treated charged particles s cp median survival times NUMBER NUMBER NUMBER months respectively entire group NUMBER NUMBER NUMBER months patients treated curative intent survival difference patients undergoing total resection compared debulking p NUMBER minor resections p NUMBER patients microscopic residual disease increased median survival times treated adjuvant irradiation markedly cp p NUMBER conventional x p NUMBER patients gross residual disease marked statistically significant extended survival p NUMBER s x p NUMBER s cp irradiatio conclusions mainstay bile duct carcinoma management maximal surgical resection patients postoperative radiotherapy gave patients positive microscopic margins significant survival advantage value selected patients gross disease charged particle follow x ray